Comparative Study Between Outcome of ICT Drainage and VATS in Management of Second Stage Empyema
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Intercostal tube, Video assisted thoracoscope.
- Who it may be relevant to
- Registry conditions: Second Stage Empyema. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparative Study Between Outcome of Inter-costal Tube Drainage and Video Assisted Thoracoscopic Surgery in Management of Second Stage Empyema
Overview
The goal of this clinical trial is to compare between outcome of inter-costal tube drainage and video assisted thoracoscopic surgery in management of patients with second stage empyema. It compares the outcome of both interventions in hospital stay, cost, wether need of decortication later on or not.
Interventions
- Procedure Intercostal tube
Intercostal tube drainage as a first management of second stage empyema - Procedure Video assisted thoracoscope
Video assisted thoracoscopic surgery as a first management for second stage empyema
Primary outcome measures
- the length of hospital stay [Time frame: From enrollment to 4 weeks]
- cost of treatment of the patients' in each group [Time frame: 4 weeks]
- number of participants with needs of decortication later on or not, assessed by the chest X-ray and CT chest. [Time frame: 4 weeks]
Eligibility criteria
Inclusion criteria
- Patients both adults and children diagnosed as Empyema thoracis in early stages based on clinical examination, imaging modalities and pleural fluid analysis
Exclusion criteria
- Empyema due to carcinoma, terminally ill patients, patients with severe respiratory distress at admission, patients not fit for surgery, patients with co morbid diseases like cardiac disorders and immunosuppression.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06680024 · Soh-Med-24-09-10MS